1. Home
  2. SQNS vs PMVP Comparison

SQNS vs PMVP Comparison

Compare SQNS & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

N/A

Current Price

$2.73

Market Cap

46.9M

Sector

Technology

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.75

Market Cap

71.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SQNS
PMVP
Founded
2003
2013
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
71.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
SQNS
PMVP
Price
$2.73
$1.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
★ $10.00
$4.20
AVG Volume (30 Days)
35.4K
★ 515.8K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.92
N/A
Revenue Next Year
$66.21
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.38
$1.02
52 Week High
$10.19
$1.88

Technical Indicators

Market Signals
Indicator
SQNS
PMVP
Relative Strength Index (RSI) 41.09 68.53
Support Level $2.72 $1.05
Resistance Level $3.19 $1.88
Average True Range (ATR) 0.17 0.11
MACD -0.02 0.02
Stochastic Oscillator 1.20 89.89

Price Performance

Historical Comparison
SQNS
PMVP

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: